We generated mice with a Ubc9 transgene (Ubc9 is the sole E2 conjugase for SUMOs), and these transgenic mice indeed showed an increased level of global SUMO-conjugation and increased tolerance to middle cerebral artery occlusion (MCAO), a focal preclinical stroke model [4]. This evidence concerns the gene UBE2I and stroke disorder.